Respiri: Raises $2M to develop wheezo respiratory device
- Health technology company Respiri (RSH) has raised $2M through a share placement
- Then the money raised to progress commercial development, sales and marketing, and FDA clearance for its wheezo technology
- wheezo is a medical device also linked to a software app which can detect the presence of wheezing
- This device help people with respiratory problems better manage their health
- Respiri has also announced plans to raise a further $1M through a share purchase plan
- This will be open from April 10 2020
